{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:09:07Z","timestamp":1794276547764,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Top Talent Support Program for young and middle-aged people of Wuxi Health Committee","award":["HB2023022"],"award-info":[{"award-number":["HB2023022"]}]},{"name":"Scientific Research Program of Wuxi Health Commission","award":["M202236"],"award-info":[{"award-number":["M202236"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14022-1","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T11:05:12Z","timestamp":1743851112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biparametric MRI-based radiomics for prediction of clinically significant prostate cancer of PI-RADS category 3 lesions"],"prefix":"10.1186","volume":"25","author":[{"given":"Feng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"14022_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"14022_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet. 2021;398:1075\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(21)00950-8.","journal-title":"Lancet"},{"key":"14022_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2214\/AJR.10.5923","volume":"197","author":"T Tamada","year":"2011","unstructured":"Tamada T, Sone T, Higashi H, Jo Y, Yamamoto A, Kanki A, et al. Prostate cancer detection in patients with total serum Prostate-Specific antigen levels of 4\u201310 Ng\/mL: diagnostic efficacy of Diffusion-Weighted imaging, dynamic Contrast-Enhanced MRI, and T2-Weighted imaging. AJR Am J Roentgenol. 2011;197:664\u201370. https:\/\/doi.org\/10.2214\/AJR.10.5923.","journal-title":"AJR Am J Roentgenol"},{"key":"14022_CR4","doi-asserted-by":"publisher","first-page":"W715","DOI":"10.2214\/AJR.10.5700","volume":"196","author":"JC Vilanova","year":"2011","unstructured":"Vilanova JC, Barcel\u00f3-Vidal C, Comet J, Boada M, Barcel\u00f3 J, Ferrer J, et al. Usefulness of prebiopsy multifunctional and morphologic MRI combined with Free-to-Total prostate-Specific antigen ratio in the detection of prostate cancer. Am J Roentgenol. 2011;196:W715\u201322. https:\/\/doi.org\/10.2214\/AJR.10.5700.","journal-title":"Am J Roentgenol"},{"key":"14022_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1464-410X.2010.09808.x","volume":"107","author":"NB Delongchamps","year":"2011","unstructured":"Delongchamps NB, Rouanne M, Flam T, Beuvon F, Liberatore M, Zerbib M, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast\u2010enhanced and diffusion\u2010weighted imaging. Bju Int. 2011;107:1411\u20138. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09808.x.","journal-title":"Bju Int"},{"key":"14022_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"JO Barentsz","year":"2012","unstructured":"Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22:746\u201357. https:\/\/doi.org\/10.1007\/s00330-011-2377-y.","journal-title":"Eur Radiol"},{"key":"14022_CR7","doi-asserted-by":"crossref","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. Eur Urol. 2016;69:16\u201340. PI-RADS Prostate Imaging\u2013 Reporting and Data System: 2015, Version 2.","DOI":"10.1016\/j.eururo.2015.08.052"},{"key":"14022_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Eur Urol. 2019;76:340\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2."},{"key":"14022_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","volume":"6","author":"M Maggi","year":"2020","unstructured":"Maggi M, Panebianco V, Mosca A, Salciccia S, Gentilucci A, Di Pierro G, et al. Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer: A systematic review and Meta-analysis. Eur Urol Focus. 2020;6:463\u201378. https:\/\/doi.org\/10.1016\/j.euf.2019.06.014.","journal-title":"Eur Urol Focus"},{"key":"14022_CR10","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s00261-023-03924-y","volume":"48","author":"LF Calimano-Ramirez","year":"2023","unstructured":"Calimano-Ramirez LF, Virarkar MK, Hernandez M, Ozdemir S, Kumar S, Gopireddy DR, et al. MRI-based nomograms and radiomics in presurgical prediction of extraprostatic extension in prostate cancer: a systematic review. Abdom Radiol. 2023;48:2379\u2013400. https:\/\/doi.org\/10.1007\/s00261-023-03924-y.","journal-title":"Abdom Radiol"},{"key":"14022_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-023-04305-2","author":"G Chiacchio","year":"2023","unstructured":"Chiacchio G, Castellani D, Nedbal C, De Stefano V, Brocca C, Tramanzoli P, et al. Radiomics vs radiologist in prostate cancer. Results from a systematic review. World J Urol. 2023. https:\/\/doi.org\/10.1007\/s00345-023-04305-2.","journal-title":"World J Urol"},{"key":"14022_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/jimaging7020034","volume":"7","author":"G Cutaia","year":"2021","unstructured":"Cutaia G, La Tona G, Comelli A, Vernuccio F, Agnello F, Gagliardo C, et al. Radiomics and prostate MRI: current role and future applications. J Imaging. 2021;7:34. https:\/\/doi.org\/10.3390\/jimaging7020034.","journal-title":"J Imaging"},{"key":"14022_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016152542","volume":"280","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Ginocchio LA, Cornfeld D, Froemming AT, Gupta RT, Turkbey B, et al. Interobserver reproducibility of the PI-RADS version 2 lexicon: A multicenter study of six experienced prostate radiologists. Radiology. 2016;280:793\u2013804. https:\/\/doi.org\/10.1148\/radiol.2016152542.","journal-title":"Radiology"},{"key":"14022_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.crad.2016.09.011","volume":"72","author":"P De Visschere","year":"2017","unstructured":"De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol. 2017;72:23\u201332. https:\/\/doi.org\/10.1016\/j.crad.2016.09.011.","journal-title":"Clin Radiol"},{"key":"14022_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.2017161316","volume":"285","author":"MD Greer","year":"2017","unstructured":"Greer MD, Shih JH, Lay N, Barrett T, Kayat Bittencourt L, Borofsky S, et al. Validation of the dominant sequence paradigm and role of dynamic Contrast-enhanced imaging in PI-RADS version 2. Radiology. 2017;285:859\u201369. https:\/\/doi.org\/10.1148\/radiol.2017161316.","journal-title":"Radiology"},{"key":"14022_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.urology.2018.08.032","volume":"122","author":"VC Obmann","year":"2018","unstructured":"Obmann VC, Pahwa S, Tabayayong W, Jiang Y, O\u2019Connor G, Dastmalchian S, et al. Diagnostic accuracy of a rapid biparametric MRI protocol for detection of histologically proven prostate cancer. Urology. 2018;122:133\u20138. https:\/\/doi.org\/10.1016\/j.urology.2018.08.032.","journal-title":"Urology"},{"key":"14022_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2214\/AJR.17.18946","volume":"211","author":"X Niu","year":"2018","unstructured":"Niu X, Chen X, Chen Z, Chen L, Li J, Peng T. Diagnostic performance of biparametric MRI for detection of prostate cancer: A systematic review and Meta-Analysis. Am J Roentgenol. 2018;211:369\u201378. https:\/\/doi.org\/10.2214\/AJR.17.18946.","journal-title":"Am J Roentgenol"},{"key":"14022_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","volume":"24","author":"EJ Bass","year":"2021","unstructured":"Bass EJ, Pantovic A, Connor M, Gabe R, Padhani AR, Rockall A, et al. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk. Prostate Cancer Prostatic Dis. 2021;24:596\u2013611. https:\/\/doi.org\/10.1038\/s41391-020-00298-w.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"14022_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2214\/AJR.20.23219","volume":"216","author":"R Cuocolo","year":"2021","unstructured":"Cuocolo R, Verde F, Ponsiglione A, Romeo V, Petretta M, Imbriaco M, et al. Clinically significant prostate cancer detection with biparametric MRI: A systematic review and Meta-Analysis. Am J Roentgenol. 2021;216:608\u201321. https:\/\/doi.org\/10.2214\/AJR.20.23219.","journal-title":"Am J Roentgenol"},{"key":"14022_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14759","author":"M Alabousi","year":"2019","unstructured":"Alabousi M, Salameh J-P, Gusenbauer K, Samoilov L, Jafri A, Yu H, et al. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-na\u00efve patients: a diagnostic test accuracy systematic review and meta-analysis. BJU Int. 2019. https:\/\/doi.org\/10.1111\/bju.14759.","journal-title":"BJU Int"},{"key":"14022_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"14022_CR22","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","volume":"34","author":"KF Kerr","year":"2016","unstructured":"Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34:2534\u201340. https:\/\/doi.org\/10.1200\/JCO.2015.65.5654.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"14022_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jclinepi.2015.12.005","volume":"74","author":"B Van Calster","year":"2016","unstructured":"Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016;74:167\u201376. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.12.005.","journal-title":"J Clin Epidemiol"},{"key":"14022_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41598-020-80749-5","volume":"11","author":"V Brancato","year":"2021","unstructured":"Brancato V, Aiello M, Basso L, Monti S, Palumbo L, Di Costanzo G, et al. Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions. Sci Rep. 2021;11:643. https:\/\/doi.org\/10.1038\/s41598-020-80749-5.","journal-title":"Sci Rep"},{"key":"14022_CR25","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.3390\/jcm11216304","volume":"11","author":"A Corsi","year":"2022","unstructured":"Corsi A, De Bernardi E, Bonaffini PA, Franco PN, Nicoletta D, Simonini R, et al. Radiomics in PI-RADS 3 multiparametric MRI for prostate cancer identification: literature models Re-Implementation and proposal of a Clinical-Radiological model. J Clin Med. 2022;11:6304. https:\/\/doi.org\/10.3390\/jcm11216304.","journal-title":"J Clin Med"},{"key":"14022_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1067\/j.cpradiol.2019.10.009","volume":"50","author":"D Giambelluca","year":"2021","unstructured":"Giambelluca D, Cannella R, Vernuccio F, Comelli A, Pavone A, Salvaggio L, et al. PI-RADS 3 lesions: role of prostate MRI texture analysis in the identification of prostate cancer. Curr Probl Diagn Radiol. 2021;50:175\u201385. https:\/\/doi.org\/10.1067\/j.cpradiol.2019.10.009.","journal-title":"Curr Probl Diagn Radiol"},{"key":"14022_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/JU.0000000000000272","volume":"202","author":"SJ Hectors","year":"2019","unstructured":"Hectors SJ, Cherny M, Yadav KK, Beksa\u00e7 AT, Thulasidass H, Lewis S, et al. Radiomics features measured with multiparametric magnetic resonance imaging predict prostate cancer aggressiveness. J Urol. 2019;202:498\u2013505. https:\/\/doi.org\/10.1097\/JU.0000000000000272.","journal-title":"J Urol"},{"key":"14022_CR28","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s00261-020-02678-1","volume":"45","author":"Y Hou","year":"2020","unstructured":"Hou Y, Bao M-L, Wu C-J, Zhang J, Zhang Y-D, Shi H-B. A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions. Abdom Radiol N Y. 2020;45:4223\u201334. https:\/\/doi.org\/10.1007\/s00261-020-02678-1.","journal-title":"Abdom Radiol N Y"},{"key":"14022_CR29","doi-asserted-by":"publisher","first-page":"840786","DOI":"10.3389\/fonc.2022.840786","volume":"12","author":"P Jin","year":"2022","unstructured":"Jin P, Yang L, Qiao X, Hu C, Hu C, Wang X, et al. Utility of Clinical-Radiomic model to identify clinically significant prostate cancer in biparametric MRI PI-RADS V2.1 category 3 lesions. Front Oncol. 2022;12:840786. https:\/\/doi.org\/10.3389\/fonc.2022.840786.","journal-title":"Front Oncol"},{"key":"14022_CR30","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1007\/s00261-021-03235-0","volume":"46","author":"CS Lim","year":"2021","unstructured":"Lim CS, Abreu-Gomez J, Thornhill R, James N, Al Kindi A, Lim AS, et al. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis. Abdom Radiol. 2021;46:5647\u201358. https:\/\/doi.org\/10.1007\/s00261-021-03235-0.","journal-title":"Abdom Radiol"},{"key":"14022_CR31","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00330-016-4663-1","volume":"27","author":"G Nketiah","year":"2017","unstructured":"Nketiah G, Elschot M, Kim E, Teruel JR, Scheenen TW, Bathen TF, et al. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol. 2017;27:3050\u20139. https:\/\/doi.org\/10.1007\/s00330-016-4663-1.","journal-title":"Eur Radiol"},{"key":"14022_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority Over-sampling technique. J Artif Intell Res. 2002;16:321\u201357. https:\/\/doi.org\/10.1613\/jair.953.","journal-title":"J Artif Intell Res"},{"key":"14022_CR33","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/0284185120905066","volume":"61","author":"A Losneg\u00e5rd","year":"2020","unstructured":"Losneg\u00e5rd A, Reis\u00e6ter LAR, Halvorsen OJ, Jurek J, Assmus J, Arnes JB, et al. Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiol. 2020;61:1570\u20139. https:\/\/doi.org\/10.1177\/0284185120905066.","journal-title":"Acta Radiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14022-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T11:05:15Z","timestamp":1743851115000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14022"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14022-1","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.eururo.2019.02.033","asserted-by":"subject"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients\u2019 data were anonymized. Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"615"}}